6-Methoxy-1H-benzo[d]imidazole-2-sulfonic acid, 97%, 100mg

tert-Butyl 5-nitroisoindoline-2-carboxylate, 95.0%, 5g

(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide, 98.0%, 250mg

3-Amino-N-(2-chlorophenyl)benzene-1-sulfonamide, 97%, 250mg

4-((tert-Butoxycarbonyl)amino)-1-methyl-1H-pyrazole-3-carboxylic acid, 98%, 1g

ARCA Cap Analog, ≥98%, 50 µl, plastic package.

n-(Furan-2-ylmethyl)ethanamine hydrochloride, 98%, 1g

1-Boc-3-vinyl-piperidine, 95.0%, 500mg

4-(3-Chlorobenzoyl)morpholine, 98%, 1g

2,5-Dioxopyrrolidin-1-yl 14-oxo-18-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-13-azaoctadecanoate, 95%, 1g

2,3-Dihydrobenzo[1,4]dioxine-2-carbonyl chloride, 1g

(3-Hydroxycyclohexyl)carbamic acid tert-butyl ester, 95.0%, 100g

3-Iodo-1-tosyl-1H-indole-5-carbonitrile, 97%, 25g